Back to Search
Start Over
[Towards new therapeutic paradigms beyond symptom control in the management of inflammatory bowel diseases.]
- Source :
-
Recenti progressi in medicina [Recenti Prog Med] 2018 Jan; Vol. 109 (1), pp. 50-58. - Publication Year :
- 2018
-
Abstract
- Inflammatory bowel diseases, Crohn's disease and ulcerative colitis are chronic relapsing conditions that may result in progressive bowel damage, high risk of complications, surgery and permanent disability. The conventional therapeutic approach for inflammatory bowel diseases is based mainly on symptom control. Unfortunately, a symptom-based therapeutic approach has little impact on major long-term disease outcomes. In other chronic disabling conditions such as diabetes, hypertension and rheumatoid arthritis, the development of new therapeutic approaches has led to better outcomes. In this context a "treat to target" strategy has been developed. This strategy is based on identification of high-risk patients, regular assessment of disease activity by means of objective measures, adjustment of treatment to reach the pre-defined target. A treat to target approach has recently been proposed for inflammatory bowel disease with the aim at modifying the natural history of the disease. In this review, the evidence and the limitations of the treat to target paradigm in inflammatory bowel disease are analyzed and discussed.
Details
- Language :
- Italian
- ISSN :
- 2038-1840
- Volume :
- 109
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Recenti progressi in medicina
- Publication Type :
- Academic Journal
- Accession number :
- 29451523
- Full Text :
- https://doi.org/10.1701/2848.28755